Immuneonco Biopharmaceutical Inc. (1541)
Market Closed
1 Sep, 08:00
HKEX 
XFRA Primary HKEX 3. 70
HKD -0.01
-0.2695%
2.28B Market Cap
- P/E Ratio
- Div Yield
582,000 Volume
- Eps
3.71 HKD
Previous Close Want to track 1541 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immuneonco Biopharmaceutical Inc. (1541) Statistics
Valuation metrics
Market Cap 2.28B
Enterprise value 1.05B
Trailing P/E (ttm) -6.12
Forward P/E -
PEG ratio -0.18
Price/Sales (ttm) 9.59
Price/Book (mrq) 2.19
Enterprise Value/Revenue 7.55
Enterprise Value/EBITDA -5.24
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 772.63K
Average volume (90 days) 1.1M
Price summary
52-Week low 2.8
52-Week high 16.8
Beta -
50-Day moving average 3.4
200-Day moving average 4.01
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.63%
Operating margin -1.54%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.32%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.32
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.58
Current ratio (mrq) 2.66%
Book value per share (mrq) 1.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
